Cell Biotech International

Cell Biotech is a global biotechnology company specializing in the research, development, and manufacturing of probiotics and microbiome-based therapeutics. The company is best known for its proprietary 'Dual Coating' technology, which enhances the survival rate of lactic acid bacteria through the digestive tract, marketed under the flagship brand Duolac. Beyond functional foods, Cell Biotech is advancing a pharmaceutical pipeline focused on microbiome-derived treatments for oncology and inflammatory diseases. Their lead therapeutic candidate, PP-P8, is a recombinant probiotic being evaluated for the treatment of colorectal cancer. Headquartered in South Korea, the company maintains a significant international presence with exports to over 40 countries.